Breast cancer Posts Page 2 on Medivizor
Navigation Menu

Breast cancer Posts on Medivizor

Breast cancer treatment with Tamoxifen and its relation to Fatty Liver Disease

Posted by on Aug 19, 2018 in Breast cancer | 0 comments

In a nutshell This study looked at the risk factors and protective factors surrounding non-alcoholic fatty liver disease in relation to tamoxifen (Novaldex) therapy for women with breast cancer. The authors found that a high BMI was a risk factor for tamoxifen related fatty liver disease, while exercise was a protective factor. Some background...

Read More

Cancer Vaccines

Cancer Vaccines

Posted by on Aug 13, 2018 in Blog, Breast cancer, Colorectal cancer, Hodgkin's lymphoma, Leukemia, Lung cancer, Lymphoma, Melanoma, Multiple Myeloma, Non-Hodgkin lymphoma, Prostate cancer | 3 comments

When I think of vaccines, I think of the MMRV (measles, mumps, rubella and varicella) vaccines which help our bodies establish immunity against diseases that used to kill.  Now, there are vaccines being created for cancer. The rise of cancer vaccines According to Dr. Nora Disis, an oncologist and researcher in cancer vaccines at the University of...

Read More

Recovery of ovarian function in breast cancer patients after protective treatment with gonadotropin-releasing hormone agonists

Posted by on Jul 23, 2018 in Breast cancer | 0 comments

In a nutshell This study looked at the factors that affected functioning of the ovaries in women who were treated with gonadotropin-releasing hormone drugs during their breast cancer treatment. The authors found that pre-treating the patients with anti-Müllerian hormone (AMH) and follicle-stimulating hormone (FSH) was beneficial in recovering...

Read More

Fulvestrant compared to aromatase inhibitors in post-menopausal women with HR+ advanced breast cancer

Posted by on Jul 16, 2018 in Breast cancer | 0 comments

In a nutshell This study aimed to look at the safety and effectiveness of fulvestrant (Faslodex) compared to aromatase inhibitors in post-menopausal women with hormone receptor-positive (HR+) breast cancer. The authors found that fulvestrant was a safe and effective treatment in these patients when compared to aromatase inhibitors. Some...

Read More

Effects of breast reconstruction compared to mastectomy only on survival and risk of recurrence of breast cancer

Posted by on Jul 16, 2018 in Breast cancer | 0 comments

Layman Title Effects of breast reconstruction compared to mastectomy only on survival and risk of recurrence of breast cancer In a nutshell This study aimed to find out if breast reconstruction using deep inferior epigastric perforator (DIEP) flap reconstruction resulted in higher levels of recurrence compared to mastectomy alone. The authors found that...

Read More

Everolimus and exemstane for treatment of HR+/HER2- advanced or metastatic breast cancer

Posted by on Jul 16, 2018 in Breast cancer | 0 comments

In a nutshell This study looked at the effectiveness and safety of a combination of two cancer drugs, everolimus (Afinitor) and exemestane (Aromasin), in women after menopause with advanced breast cancer. The authors found that these drugs were safe and effective in the treatment of these women. Some background Breast cancer is...

Read More